CarbaMic acid, N-[(1R)-1-[3-[6-(trifluoroMethyl)-1H-benziMidazol-2-yl]-5-isoxazolyl]ethyl]-, 1,1-diMethylethyl ester → 5-IsoxazoleMethanaMine, α-Methyl-3-[6-(trifluoroMethyl)-1H-benziMidazol-2-yl]-, (αR)-

HRID 2066913Notes

Reaction equation

HRID 2066913 reaction equation
[F:1][C:2]([F:28])([F:27])[C:3]1[CH:4]=[CH:5][C:6]2[N:10]=[C:9]([C:11]3[CH:15]=[C:14]([C@H:16]([NH:18]C(=O)OC(C)(C)C)[CH3:17])[O:13][N:12]=3)[NH:8][C:7]=2[CH:26]=1>C(O)(C(F)(F)F)=O>[F:28][C:2]([F:1])([F:27])[C:3]1[CH:4]=[CH:5][C:6]2[N:10]=[C:9]([C:11]3[CH:15]=[C:14]([C@H:16]([NH2:18])[CH3:17])[O:13][N:12]=3)[NH:8][C:7]=2[CH:26]=1

Participants

3

Procedure

A mixture of (R)-tert-butyl 1-(3-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)isoxazol-5-yl)ethylcarbamate (86.5 g, 0.22 mol) in TFA (300 mL) was stirred at RT for 2 hr. The reaction mixture was concentrated in vacuo and re-dissolved in ethyl acetate. The ethyl acetate solution was washed with K2CO3 and water, dried over Na2SO4, and concentrated. The crude product was purified by column chromatography to afford compound Na, (R)-1-(3-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)isoxazol-5-yl)ethanamine (30.2 g, 46.7%). 1H NMR (DMSO-d6) δ 7.98 (s, 1H), 7.78 (d, 1 H), 7.56 (d, 1H), 6.94 (s, 1H), 4.16 (q, 1H), 1.36 (d, 3H).

Workup

  1. concentrationThe reaction mixture was concentrated in vacuo
  2. dissolutionre-dissolved in ethyl acetate
  3. washThe ethyl acetate solution was washed with K2CO3 and water
  4. dry with materialdried over Na2SO4
  5. concentrationconcentrated
  6. customThe crude product was purified by column chromatography

Sources & evidence

ORD record
ord-6150b791a84e49878a6d714ccdcc8b98
Source dataset
uspto-grants-2012_10
Patent number
US08293752B2

Reaction notes

Loading…